Last Round
Series B
Jul 18, 2025
Total Funding Raised
$7.82M
Company Overview
Link Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Kyoto. Its latest recorded funding round was a Series B round in July 2025.
Link Therapeutics, Inc. is a biotechnology company that develops therapeutic methods for targeting and identifying pathogenic autoantibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Link Therapeutics, Inc. Comparables
Compare Link Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensho Therapeutics | 71% | |
| Eli Lilly and Company | 69% | |
| Eisai | 65% |
For institutional investors. Book with your work email.
Link Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 18, 2025 | ||||
| Series A | Feb 28, 2023 |
For institutional investors. Book with your work email.
Link Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ITOCHU Technology Ventures | Series B |
| Kobe University Capital | Series B |
| Mitsubishi UFJ Capital | Series A |
| ITOCHU Technology Ventures | Series B |
| Kyoto University Innovation Capital | Series A, Series B |
| SMBC Venture Capital | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2025
$6M round with ITOCHU Technology Ventures and SMBC Venture Capital.
For institutional investors. Book with your work email.
Link Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Link Therapeutics, Inc.'s valuation, stock price, and market status.
Is Link Therapeutics, Inc. a public or private company?
Link Therapeutics, Inc. is a private company.
What is the current stock price of Link Therapeutics, Inc.?
Link Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Link Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Link Therapeutics, Inc. worth (valuation)?
Valuation information for Link Therapeutics, Inc. is not publicly available.
Can I buy Link Therapeutics, Inc. stock?
Link Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Link Therapeutics, Inc.'s last funding round?
Link Therapeutics, Inc.'s most recent funding round was Series B on July 18, 2025.
Who are the main investors in Link Therapeutics, Inc.?
Key investors in Link Therapeutics, Inc. include ITOCHU Technology Ventures, Kobe University Capital, Mitsubishi UFJ Capital, ITOCHU Technology Ventures, Kyoto University Innovation Capital.
Will Link Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Link Therapeutics, Inc..
How can I track Link Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Link Therapeutics, Inc.'s shares on secondary markets.